Structural and functional changes of the heart in patients with coronary heart disease who have had coronavirus disease COVID-19
DOI:
https://doi.org/10.14739/mmt.2024.2.301678Keywords:
ischemic heart disease, coronavirus disease COVID-19, left ventricular remodeling, structural and functional state of the heart, echocardiography, riskAbstract
The aim of the study: to investigate the effect of the previous COVID-19 coronavirus disease on the features of cardiac remodeling in patients with coronary heart disease (CHD).
Materials and methods. 71 patients with CHD were involved in the study: stable angina pectoris II–III FC (age 69.0 (64.0; 76.0) years): 1 group (main) – 31 patients with CHD in long COVID-19 period; group 2 (comparison) – 40 patients with CHD without a history of COVID-19. Features of cardiac remodeling and energy work of the left ventricular (LV) myocardium were assessed using the echocardiography method.
Results. CHD patients with a history of COVID-19 had greater changes in linear and volumetric parameters of the heart, an increase in the degree of hypertrophy of the LV myocardium, frequency of registration of LV diastolic dysfunction against the background of an increase in the mean pressure in the pulmonary artery, end-systolic pressure, decrease in global LV contractile function (LVF) compared to patients without COVID-19 history (p < 0.05). In CHD patients who suffered from COVID-19, there was an increase in the estimated energy expenditure of the LV myocardium: shock work by 14.77 % (U = 461.5; p < 0.05), potential energy by 34.68 % (U = 316.5; p < 0.05) and the pressure-volume zone by 17.78 % (U = 373.0; p < 0.05), which indicates a decrease in the speed of myocardial recovery in long COVID period. It was established that the presence of COVID-19 in the history of patients with CHD is associated with an increased risk of LV dilatation by 5.6 times (95 % CI 1.71–18.29; p < 0.05), LV myocardial hypertrophy by 3.05 times (95 % CI 1.79–5.91; p < 0.05), LV diastolic dysfunction by 1.44 times (95 % CI 0.91–2.29; p < 0.05), an increase in energy expenditure during heart work by 1.66 times (95 % CI 0.68–4.02; p < 0.05).
Conclusions. Patients with coronary heart disease have more significant structural and functional changes and energy expenditure during the work of the heart, which proves the negative impact of SARS-CoV-2 on the state of cardiac remodeling in patients with CHD in long COVID-19 period.
References
Kovalenko VM, Nesukay EG, Kornienko TM, Titova NS. [COVID-19 pandemic and cardiovascular disease]. Ukrainian Journal of Cardiology. 2020;27(2):10-7. Russian. doi: https://doi.org/10.31928/1608-635x-2020.2.1017
Netiazhenko VZ, Mostovyi SE, Safonova OM. [The Impact of COVID-19 upon Intracardiac Hemodynamics and Heart Rate Variability in Stable Coronary Artery Disease Patients]. Ukrainian Journal of Cardiovascular Surgery. 2023;31(1):19-28. Ukrainian. doi: https://doi.org/10.30702/ujcvs/23.31(01)/nm009-1928
Stefanini GG, Montorfano M, Trabattoni D, Andreini D, Ferrante G, Ancona M, et al. ST-Elevation Myocardial Infarction in Patients With COVID-19. Circulation. 2020;141(25):2113-6. doi: https://doi.org/10.1161/circulationaha.120.047525
Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27(4):1-15. doi: https://doi.org/10.1038/s41591-021-01283-z
Pagliaro BR, Cannata F, Stefanini GG, Bolognese L. Myocardial ischemia and coronary disease in heart failure. Heart Fail Rev. 2020;25(1):53-65. doi: https://doi.org/10.1007/s10741-019-09831-z
Tudoran M, Tudoran C, Lazureanu VE, Marinescu AR, Pop GN, Pescariu AS, et al. Alterations of Left Ventricular Function Persisting during Post-Acute COVID-19 in Subjects without Previously Diagnosed Cardiovascular Pathology. J Pers Med. 2021;11(3):225. doi: https://doi.org/10.3390/jpm11030225
Tashchuk V, Nesterovska R, Kalarash V. [The connection between hospital mortality and inflamation markers in COVID-19 patients and ischaemic heart disease]. Bukovinian medical herald. 2021;25(3):118-23. Ukrainian. doi: https://doi.org/10.24061/2413-0737.xxv.3.99.2021.18
Oikonomou E, Souvaliotis N, Lampsas S, Siasos G, Poulakou G, Theofilis P, et al. Endothelial dysfunction in acute and long standing COVID-19: A prospective cohort study. Vascul Pharmacol. 2022;144:106975. doi: https://doi.org/10.1016/j.vph.2022.106975
Buheruk VV, Voloshyna OB, Balashova ІV. [Inflammatory damage to the myocardium in patients with novel coronavirus disease (COVID-19)]. Zaporozhye medical journal. 2021;23(4):555-65. Ukrainian. doi: https://doi.org/10.14739/2310-1210.2021.4.211033
Mohammad KO, Lin A, Rodriguez JBC. Cardiac Manifestations of Post-Acute COVID-19 Infection. Curr Cardiol Rep. 2022;24(12):1775-83. doi: https://doi.org/10.1007/s11886-022-01793-3
Huseynov A, Akin I, Duerschmied D, Scharf RE. Cardiac Arrhythmias in Post-COVID Syndrome: Prevalence, Pathology, Diagnosis, and Treatment. Viruses. 2023;15(2):389. doi: https://doi.org/10.3390/v15020389
Honchar OV. [Structural and functional remodeling of the heart in hypertensive patients with COVID-19: assessmentof changes at the end of hospitalization period and during a 1-month follow-up]. Ukrainian Journal of Cardiology. 2023;30(5-6):7-18. Ukrainian. doi: https://doi.org/10.31928/2664-4479-2023.5-6.718
Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395(10234):1417-8. doi: https://doi.org/10.1016/S0140-6736(20)30937-5
Fox SE, Akmatbekov A, Harbert JL, Li G, Quincy Brown J, Vander Heide RS. Pulmonary and cardiac pathology in African American patients with COVID-19: an autopsy series from New Orleans. Lancet Respir Med. 2020;8(7):681-6. doi: https://doi.org/10.1016/S2213-2600(20)30243-5
Samokhina LM, Rudyk IS. [Features of heart failure in patients who have contracted a coronavirus infection]. Fiziolohichnyi zhurnal. 2022;68(6):90-9. Ukrainian. doi: https://doi.org/10.15407/fz68.06.090
Bader F, Manla Y, Atallah B, Starling RC. Heart failure and COVID-19. Heart Fail Rev. 2021;26(1):1-10. doi: https://doi.org/10.1007/s10741-020-10008-2
Ikonomidis I, Aboyans V, Blacher J, Brodmann M, Brutsaert DL, Chirinos JA, et al. The role of ventricular-arterial coupling in cardiac disease and heart failure: assessment, clinical implications and therapeutic interventions. A consensus document of the European Society of Cardiology Working Group on Aorta & Peripheral Vascular Diseases, European Association of Cardiovascular Imaging, and Heart Failure Association. Eur J Heart Fail. 2019;21(4):402-24. doi: https://doi.org/10.1002/ejhf.1436
Bodretska LA, Shapovalenko IS, Antonyuk-Shcheglova IA, Bondarenko OV, Naskalova SS, Shatilo VB. [Use of indicators of stiffness and energy of the myocardium as markers of aging of the cardiovascular system]. Fiziolohichnyi zhurnal. 2022;68(4):3-10. Ukrainian. doi: https://doi.org/10.15407/fz68.04.003
Manuilov SM, Mikhailovska NS. [Characteristics of neurovegetative disorders in ischemic heart disease patients after coronavirus disease 2019 (COVID-19)]. Zaporozhye medical journal. 2024;26(2):106-13. Ukrainian. doi: https://doi.org/10.14739/2310-1210.2024.2.297015
Raman B, Bluemke DA, Lüscher TF, Neubauer S. Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus. Eur Heart J. 2022;43(11):1157-72. doi: https://doi.org/10.1093/eurheartj/ehac031
Karagodin I, Carvalho Singulane C, Woodward GM, Xie M, Tucay ES, Tude Rodrigues AC, et al. Echocardiographic Correlates of In-Hospital Death in Patients with Acute COVID-19 Infection: The World Alliance Societies of Echocardiography (WASE-COVID) Study. J Am Soc Echocardiogr. 2021;34(8):819-30. doi: https://doi.org/10.1016/j.echo.2021.05.010
Szekely Y, Lichter Y, Taieb P, Banai A, Hochstadt A, Merdler I, et al. Spectrum of Cardiac Manifestations in COVID-19: A Systematic Echocardiographic Study. Circulation. 2020;142(4):342-53. doi: https://doi.org/10.1161/CIRCULATIONAHA.120.047971
Catena C, Colussi G, Bulfone L, Da Porto A, Tascini C, Sechi LA. Echocardiographic Comparison of COVID-19 Patients with or without Prior Biochemical Evidence of Cardiac Injury after Recovery. J Am Soc Echocardiogr. 2021;34(2):193-5. doi: https://doi.org/10.1016/j.echo.2020.10.009
Magoon R. Left-ventricular diastolic dysfunction in coronavirus disease: opening Pandora's box! Korean J Anesthesiol. 2021;74(6):557-8. doi: https://doi.org/10.4097/kja.21010
Bitar ZI, Shamsah M, Bamasood OM, Maadarani OS, Alfoudri H. Point-of-Care Ultrasound for COVID-19 Pneumonia Patients in the ICU. J Cardiovasc Imaging. 2021;29(1):60-8. doi: https://doi.org/10.4250/jcvi.2020.0138
Paulus WJ, Zile MR. From Systemic Inflammation to Myocardial Fibrosis: The Heart Failure With Preserved Ejection Fraction Paradigm Revisited. Circ Res. 2021;128(10):1451-67. doi: https://doi.org/10.1161/CIRCRESAHA.121.318159
Correia M, Santos F, da Silva Ferreira R, Ferreira R, Bernardes de Jesus B, Nóbrega-Pereira S. Metabolic Determinants in Cardiomyocyte Function and Heart Regenerative Strategies. Metabolites. 2022;12(6):500. doi: https://doi.org/10.3390/metabo12060500
Gandoy-Fieiras N, Gonzalez-Juanatey JR, Eiras S. Myocardium Metabolism in Physiological and Pathophysiological States: Implications of Epicardial Adipose Tissue and Potential Therapeutic Targets. Int J Mol Sci. 2020;21(7):2641. doi: https://doi.org/10.3390/ijms21072641
